Jefferies Financial Group purchased 3,514,833 shares of Roivant Sciences in a fourth-quarter filing.
The investment is valued at approximately $76.3 million.
Roivant now ranks as the firm's 26th largest holding.
Institutional investors and hedge funds collectively own 64.76% of the company's stock.
UBS Group and Vanguard Group Inc. also recently increased their positions.
The purchase follows Roivant’s May 20 earnings report which exceeded analyst estimates.
Several research firms raised their price targets following the financial results.